Any company that aspires to prove the safety and effectiveness of a peptide will turn away from them, knowing that compounders will simply be able to sell them without ever needing to generate safety and effectiveness evidence. Indeed, Lurie continued, financial analysts are predicting a $2.2 billion telehealth marketing opportunity if these peptides are approved for compounding
Essentially zero side effects, stable effective dose, consistent appetite suppression, weight maintenance at new lower set point
Also, a 'professional' giving another an injection will be aware of libel actions if using an expired ampoule etc
Research has shown that BPC157 can promote the repair of various tissue injuries such as skin, fractures, ligaments, muscles, nerves, and internal organs